A Phase IIa Clinical Trial to Evaluate the Efficacy and Safety of Intravenous Infusion of hUC-MSCs in Patients With AIS — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(1 site)
China
Beijing Tiantan Hospital, Capital Medical University, Beijing, Beijing Municipality Age range
18 Years – 75 Years
Last updated September 2025